- Home
- CNET vs CHRO Comparison
CNET vs CHRO Comparison
Compare CNET & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNET
- CHRO
- Stock Information
- Founded
- CNET 2003
- CHRO 2002
- Country
- CNET China
- CHRO United States
- Employees
- CNET N/A
- CHRO N/A
- Industry
- CNET Advertising
- CHRO
- Sector
- CNET Consumer Discretionary
- CHRO
- Exchange
- CNET Nasdaq
- CHRO Nasdaq
- Market Cap
- CNET 4.2M
- CHRO 4.2M
- IPO Year
- CNET N/A
- CHRO 2024
- Fundamental
- Price
- CNET $1.74
- CHRO $0.59
- Analyst Decision
- CNET
- CHRO Strong Buy
- Analyst Count
- CNET 0
- CHRO 1
- Target Price
- CNET N/A
- CHRO N/A
- AVG Volume (30 Days)
- CNET 18.0K
- CHRO 121.3K
- Earning Date
- CNET 11-19-2024
- CHRO 11-13-2024
- Dividend Yield
- CNET N/A
- CHRO N/A
- EPS Growth
- CNET N/A
- CHRO N/A
- EPS
- CNET N/A
- CHRO N/A
- Revenue
- CNET $18,458,000.00
- CHRO N/A
- Revenue This Year
- CNET N/A
- CHRO N/A
- Revenue Next Year
- CNET N/A
- CHRO N/A
- P/E Ratio
- CNET N/A
- CHRO N/A
- Revenue Growth
- CNET N/A
- CHRO N/A
- 52 Week Low
- CNET $1.47
- CHRO $0.45
- 52 Week High
- CNET $4.96
- CHRO $6.00
- Technical
- Relative Strength Index (RSI)
- CNET 44.10
- CHRO 48.49
- Support Level
- CNET $1.62
- CHRO $0.55
- Resistance Level
- CNET $1.85
- CHRO $0.71
- Average True Range (ATR)
- CNET 0.11
- CHRO 0.10
- MACD
- CNET 0.01
- CHRO -0.00
- Stochastic Oscillator
- CNET 25.00
- CHRO 23.98
About CNET ZW Data Action Technologies Inc.
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as the related data and technical services to small and medium enterprises in the PRC. It offers a variety channels of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of ecommerce O2O advertising and marketing services and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.